Evidence map›Paper›PMID 32388227›Full record

ArticlePsychoneuroendocrinology2020

Timing of menarche and abnormal hippocampal connectivity in youth at clinical-high risk for psychosis.

Katherine S F Damme, Ivanka Ristanovic, Teresa Vargas, Vijay A Mittal

Open access · greenAbstract read
In one paragraph

Article in Psychoneuroendocrinology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Estrogen and psychosis - a review and future directions.Archives of women's mental health · 2024
    Review
  5. Motor precision deficits in clinical high risk for psychosis.European archives of psychiatry and clinical neuroscience · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Katherine S F DammeDepartment of Psychology, Northwestern University, Evanston, IL, USA. Electronic address: Kate.Damme@u.northwestern.edu.
Ivanka RistanovicDepartment of Psychology, Northwestern University, Evanston, IL, USA.
Teresa VargasDepartment of Psychology, Northwestern University, Evanston, IL, USA.
Vijay A MittalDepartment of Psychology, Northwestern University, Evanston, IL, USA; Department of Psychiatry, Northwestern University, Chicago, IL, USA; Medical Social Sciences, Northwestern University, Chicago, IL, USA; Institute for Policy Research (IPR), Northwestern University, Chicago, IL, USA; Institute for Innovations in Developmental Sciences (DevSci), Northwestern University, Evanston and Chicago, IL, USA.
Northwestern University · USHealth Innovations (United States) · US

Funding

Frontal-Subcortical Development, Movement Abnormalities, and Risk for PsychosisR01MH094650 · NIMH · UNIVERSITY OF COLORADO · PI MITTAL, VIJAY A · 2011 to 2015
$2.3M
2/3 Community psychosis risk screening: An instrument development studyR01MH112545 · NIMH · NORTHWESTERN UNIVERSITY · PI MITTAL, VIJAY A · 2017 to 2021
$1.2M
Exercise and markers of medial temporal health in youth at-risk for psychosisR33MH103231 · NIMH · NORTHWESTERN UNIVERSITY · PI BRYAN, ANGELA, MITTAL, VIJAY A · 2016 to 2018
$689k
Exercise and markers of medial temporal health in youth at-risk for psychosisR21MH103231 · NIMH · UNIVERSITY OF COLORADO · PI BRYAN, ANGELA, MITTAL, VIJAY A · 2014 to 2015
$489k
NIMH NIH HHS R01 MH094650NIMH NIH HHS R01 MH112545NIMH NIH HHS R21 MH103231NIMH NIH HHS R33 MH103231
6 · The paper itself

Abstract

The "estrogen hypothesis" suggests that estrogen is a protective factor against psychotic disorders such as schizophrenia. Although the precise protective mechanisms are still unclear, one potential explanation lies in the role that increased estrogens play in mediating hippocampal plasticity, as this may reduce hippocampal dysconnectivity that is characteristically observed in psychosis. In support of this view, later age at menarche- less available estrogen during critical early adolescent development- is related to earlier onset of psychosis and increased symptom severity. Furthermore, if estrogens have protective effects, then we should see this effect in the psychosis risk period in those at clinical high-risk (CHR) for psychosis - i.e., individuals showing attenuated symptoms at imminent risk for transitioning to a psychotic diagnosis. This study examined whether earlier age at menarche would result in more normative hippocampal connectivity in CHR youth; menarche is an easily assessed, developmental marker associated with the availability of estrogens. Resting-state connectivity was examined in sixty female participants (26 CHR and 34 healthy control; age 12-21) using a cross-sectional approach; hippocampal connectivity was found to relate to age at menarche. Later age at menarche in the CHR group related to increased hippocampal dysconnectivity to the occipital cortex (a region with a neurotrophic response to estrogen) compared to the controls. Results suggest that earlier availability of estrogens may have neuroprotective effects on hippocampal plasticity. Findings have relevance for understanding sex differences and etiology, as well as guiding novel treatments.

Indexed as

ConnectomeAdolescentAdultAge FactorsChildCross-Sectional StudiesEstrogensFemaleHippocampusHuman DevelopmentHumansMagnetic Resonance ImagingMenarcheNeuronal PlasticityOccipital LobeProdromal SymptomsEstrogensConnectivityDevelopmentEstrogenHippocampusProdromePsychosis

Identifiers

PMID32388227
PMCPMC7305941
OpenAlexW3023296729

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.